The in vitro and in vivo effects of a low-molecular-weight fucoidan on the osteogenic capacity of human adipose-derived stromal cells

Tissue Engineering - Part A

Volumn 20, Issue 1-2, 2014, Pages 275-284

  Pereira, Jessica ^a,b   Portron, Sophie ^c   Dizier, Blandine ^b   Vinatier, Claire ^c   Masson, Martial ^c   Sourice, Sophie ^c   Galy Fauroux, Isabelle ^a,b   Corre, Pierre ^c,d   Weiss, Pierre ^c,d   Fischer, Anne Marie ^a,b,e   Guicheux, Jérôme ^c,d   Helley, Dominique ^a,b,e  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b INSERM   (France)

^c UNIVERSITÉ DE NANTES   (France)

^d NANTES UNIVERSITY HOSPITAL   (France)

^e HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATION ANALYSIS; BIOMATERIALS; CELL DEATH; PHOSPHATASES; STEM CELLS; TISSUE ENGINEERING;

ADIPOSE-DERIVED STROMAL CELLS; ALKALINE PHOSPHATASE; BIPHASIC CALCIUM PHOSPHATES; BONE TISSUE ENGINEERING; LOW MOLECULAR WEIGHT; LOW-MOLECULAR WEIGHT HEPARINS; OSTEOGENIC DIFFERENTIATION; SULFATED POLYSACCHARIDES;

BONE;

ALKALINE PHOSPHATASE; CALCIUM PHOSPHATE; FUCOIDIN; LOW MOLECULAR WEIGHT FUCOIDIN; LOW MOLECULAR WEIGHT HEPARIN; MESSENGER RNA; OSTEOPONTIN; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

ADIPOSE DERIVED STROMA CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BONE GROWTH; BONE REMODELING; CALCIFICATION; CELL ADHESION; CELL DEATH; CELL DIFFERENTIATION; CELL TRANSPLANTATION; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSSIFICATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; STROMA CELL;

ADIPOSE TISSUE; ANIMALS; CELL DIFFERENTIATION; CELL SURVIVAL; CELLS, CULTURED; HUMANS; HYDROXYAPATITES; MALE; MICE; MODELS, ANIMAL; MOLECULAR WEIGHT; OSTEOGENESIS; PHENOTYPE; POLYSACCHARIDES; STROMAL CELLS;

EID: 84891525165     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2013.0028     Document Type: Article

References (58)

1. Szpalski, C., Wetterau, M., Barr, J., and Warren, S.M. Bone tissue engineering: current strategies and techniques - part I: Scaffolds. Tissue Eng Part B Rev 18, 246, 2012.
2. Habraken, W.J., Wolke, J.G., and Jansen, J.A. Ceramic composites as matrices and scaffolds for drug delivery in tissue engineering. Adv Drug Deliv Rev 59, 234, 2007.
3. Gimble, J., and Guilak, F. Adipose-derived adult stem cells: isolation, characterization, and differentiation potential. Cytotherapy 5, 362, 2003.
4. Pittenger, M.F., Mackay, A.M., Beck, S.C., Jaiswal, R.K., Douglas, R., Mosca, J.D., Moorman, M.A., Simonetti, D.W., Craig, S., and Marshak, D.R. Multilineage potential of adult human mesenchymal stem cells. Science 284, 143, 1999.
5. Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F., Krause, D., Deans, R., Keating, A., Prockop, D., and Horwitz, E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8, 315, 2006.
6. Merceron, C., Vinatier, C., Clouet, J., Colliec-Jouault, S., Weiss, P., and Guicheux, J. Adipose-derived mesenchymal stem cells and biomaterials for cartilage tissue engineering. Joint Bone Spine 75, 672, 2008.
7. Supronowicz, P., Gill, E., Trujillo, A., Thula, T., Zhukauskas, R., Ramos, T., and Cobb, R.R. Human adipose-derived side population stem cells cultured on demineralized bone matrix for bone tissue engineering. Tissue Eng Part A 17, 789, 2011.
8. Gaiba, S., Franca, L.P., Franca, J.P., and Ferreira, L.M. Characterization of human adipose-derived stem cells. Acta Cir Bras 27, 471, 2012.
9. Ciuffi, S., Fabbri, S., Zonefrati, R., Galli, G., Tanini, A., and Brandi, M.L. Subcutaneous adipocytes may become osteoblasts. Clin Cases Miner Bone Metab 9, 28, 2012.
10. Dmitrieva, R.I., Minullina, I.R., Bilibina, A.A., Tarasova, O.V., Anisimov, S.V., and Zaritskey, A.Y. Bone marrow- and subcutaneous adipose tissue-derived mesenchymal stem cells: differences and similarities. Cell Cycle 11, 377, 2012.
11. Lerouxel, E., Weiss, P., Giumelli, B., Moreau, A., Pilet, P., Guicheux, J., Corre, P., Bouler, J.M., Daculsi, G., and Malard, O. Injectable calcium phosphate scaffold and bone marrow graft for bone reconstruction in irradiated areas: an experimental study in rats. Biomaterials 27, 4566, 2006.
12. Malard, O., Guicheux, J., Bouler, J.M., Gauthier, O., de Montreuil, C.B., Aguado, E., Pilet, P., LeGeros, R., and Daculsi, G. Calcium phosphate scaffold and bone marrow for bone reconstruction in irradiated area: a dog study. Bone 36, 323, 2005.
13. Espitalier, F., Vinatier, C., Lerouxel, E., Guicheux, J., Pilet, P., Moreau, F., Daculsi, G., Weiss, P., and Malard, O. A comparison between bone reconstruction following the use of mesenchymal stem cells and total bone marrow in association with calcium phosphate scaffold in irradiated bone. Biomaterials 30, 763, 2009.
14. Bose, S., and Tarafder, S. Calcium phosphate ceramic systems in growth factor and drug delivery for bone tissue engineering: a review. Acta Biomater 8, 1401, 2012.
15. Senni, K., Pereira, J., Gueniche, F., Delbarre-Ladrat, C., Sinquin, C., Ratiskol, J., Godeau, G., Fischer, A.M., Helley, D., and Colliec-Jouault, S. Marine polysaccharides: a source of bioactive molecules for cell therapy and tissue engineering. Mar Drugs 9, 1664, 2011.
16. Chabut, D., Fischer, A.M., Colliec-Jouault, S., Laurendeau, I., Matou, S., Le Bonniec, B., and Helley, D. Low molecular weight fucoidan and heparin enhance the basic fibroblast growth factor-induced tube formation of endothelial cells through heparan sulfate-dependent alpha6 overexpression. Mol Pharmacol 64, 696, 2003.
17. Park, S.J., Lee, K.W., Lim, D.S., and Lee, S. The sulfated polysaccharide fucoidan stimulates osteogenic differentiation of human adipose-derived stem cells. Stem Cells Dev 21, 2204, 2012.
18. Changotade, S.I., Korb, G., Bassil, J., Barroukh, B., Willig, C., Colliec-Jouault, S., Durand, P., Godeau, G., and Senni, K. Potential effects of a low-molecular-weight fucoidan extracted from brown algae on bone biomaterial osteoconductive properties. J Biomed Mater Res A 87, 666, 2008.
19. Nardella, A., Chaubet, F., Boisson-Vidal, C., Blondin, C., Durand, P., and Jozefonvicz, J. Anticoagulant low molecular weight fucans produced by radical process and ion exchange chromatography of high molecular weight fucans extracted from the brown seaweed Ascophyllum nodosum. Carbohydr Res 289, 201, 1996.
20. Merceron, C., Portron, S., Masson, M., Fellah, B.H., Gauthier, O., Lesoeur, J., Cherel, Y., Weiss, P., Guicheux, J., and Vinatier, C. Cartilage tissue engineering: From hydrogel to mesenchymal stem cells. Biomed Mater Eng 20, 159, 2010.
21. Willbold, E., and Witte, F. Histology and research at the hard tissue-implant interface using Technovit 9100 New embedding technique. Acta Biomater 6, 4447, 2010.
22. Trojani, C., Boukhechba, F., Scimeca, J.C., Vandenbos, F., Michiels, J.F., Daculsi, G., Boileau, P., Weiss, P., Carle, G.F., and Rochet, N. Ectopic bone formation using an injectable biphasic calcium phosphate/Si-HPMC hydrogel composite loaded with undifferentiated bone marrow stromal cells. Biomaterials 27, 3256, 2006.
23. Wongchuensoontorn, C., Liebehenschel, N., Schwarz, U., Schmelzeisen, R., Gutwald, R., Ellis, E., 3rd, and Sauerbier, S. Application of a new chair-side method for the harvest of mesenchymal stem cells in a patient with nonunion of a fracture of the atrophic mandible - a case report. J Craniomaxillofac Surg 37, 155, 2009.
24. Hernigou, P., Poignard, A., Beaujean, F., and Rouard, H. Percutaneous autologous bone-marrow grafting for nonunions. Influence of the number and concentration of progenitor cells. J Bone Joint Surg Am 87, 1430, 2005.
25. Zuk, P.A., Zhu, M., Mizuno, H., Huang, J., Futrell, J.W., Katz, A.J., Benhaim, P., Lorenz, H.P., and Hedrick, M.H. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7, 211, 2001.
26. Zuk, P.A., Zhu, M., Ashjian, P., De Ugarte, D.A., Huang, J.I., Mizuno, H., Alfonso, Z.C., Fraser, J.K., Benhaim, P., and Hedrick, M.H. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13, 4279, 2002.
27. Zhu, Y., Liu, T., Song, K., Fan, X., Ma, X., and Cui, Z. Adipose- derived stem cell: a better stem cell than BMSC. Cell Biochem Funct 26, 664, 2008.
28. Shi, Y.Y., Nacamuli, R.P., Salim, A., and Longaker, M.T. The osteogenic potential of adipose-derived mesenchymal cells is maintained with aging. Plastic Reconstr Surg 116, 1686, 2005.
29. Li, B., Lu, F., Wei, X., and Zhao, R. Fucoidan: structure and bioactivity. Molecules 13, 1671, 2008.
30. Jiao, X., Billings, P.C., O'Connell, M.P., Kaplan, F.S., Shore, E.M., and Glaser, D.L. Heparan sulfate proteoglycans (HSPGs) modulate BMP2 osteogenic bioactivity in C2C12 cells. J Biol Chem 282, 1080, 2007.
31. Mafi, P., Hindocha, S., Mafi, R., Griffin, M., and Khan, W.S. Adult mesenchymal stem cells and cell surface characterization - a systematic review of the literature. Open Orthop J 5, 253, 2011.
32. Huang, Z., Nelson, E.R., Smith, R.L., and Goodman, S.B. The sequential expression profiles of growth factors from osteoprogenitors [correction of osteroprogenitors] to osteoblasts in vitro. Tissue Eng 13, 2311, 2007.
33. Aubin, J.E. Regulation of osteoblast formation and function. Rev Endocr Metab Disord 2, 81, 2001.
34. Quarles, L.D., Yohay, D.A., Lever, L.W., Caton, R., and Wenstrup, R.J. Distinct proliferative and differentiated stages of murine MC3T3-E1 cells in culture: an in vitro model of osteoblast development. J Bone Miner Res 7, 683, 1992.
35. McKee, M.D., Pedraza, C.E., and Kaartinen, M.T. Osteopontin and wound healing in bone. Cells Tissues Organs 194, 313, 2011.
36. Hoemann, C.D., El-Gabalawy, H., and McKee, M.D. In vitro osteogenesis assays: influence of the primary cell source on alkaline phosphatase activity and mineralization. Pathol Biol (Paris) 57, 318, 2009.
37. Lee, K.S., Kim, H.J., Li, Q.L., Chi, X.Z., Ueta, C., Komori, T., Wozney, J.M., Kim, E.G., Choi, J.Y., Ryoo, H.M., and Bae, S.C. Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol Cell Biol 20, 8783, 2000.
38. Chen, G., Deng, C., and Li, Y.P. TGF-beta and BMP signaling in osteoblast differentiation and bone formation. Int J Biol Sci 8, 272, 2012.
39. Enomoto, H., Furuichi, T., Zanma, A., Yamana, K., Yoshida, C., Sumitani, S., Yamamoto, H., Enomoto-Iwamoto, M., Iwamoto, M., and Komori, T. Runx2 deficiency in chondrocytes causes adipogenic changes in vitro. J Cell Sci 117, 417, 2004.
40. Giraux, J.L., Matou, S., Bros, A., Tapon-Bretaudiere, J., Letourneur, D., and Fischer, A.M. Modulation of human endothelial cell proliferation and migration by fucoidan and heparin. Eur J Cell Biol 77, 352, 1998.
41. Lyon, M., Rushton, G., Askari, J.A., Humphries, M.J., and Gallagher, J.T. Elucidation of the structural features of heparan sulfate important for interaction with the Hep-2 domain of fibronectin. J Biol Chem 275, 4599, 2000.
42. Ostrovsky, O., Berman, B., Gallagher, J., Mulloy, B., Fernig, D.G., Delehedde, M., and Ron, D. Differential effects of heparin saccharides on the formation of specific fibroblast growth factor (FGF) and FGF receptor complexes. J Biol Chem 277, 2444, 2002.
43. Velard, F., Braux, J., Amedee, J., and Laquerriere, P. Inflammatory cell response to calcium phosphate biomaterial particles: an overview. Acta Biomater 9, 4956, 2013.
44. Lovett, M., Lee, K., Edwards, A., and Kaplan, D.L. Vascularization strategies for tissue engineering. Tissue Eng Part B Rev 15, 353, 2009.
45. Rivron, N.C., Liu, J.J., Rouwkema, J., de Boer, J., and van Blitterswijk, C.A. Engineering vascularised tissues in vitro. Eur Cell Mater 15, 27, 2008.
46. Rouwkema, J., Rivron, N.C., and van Blitterswijk, C.A. Vascularization in tissue engineering. Trends Biotechnol 26, 434, 2008.
47. Deschepper, M., Oudina, K., David, B., Myrtil, V., Collet, C., Bensidhoum, M., Logeart-Avramoglou, D., and Petite, H. Survival and function of mesenchymal stem cells (MSCs) depend on glucose to overcome exposure to longterm, severe and continuous hypoxia. J Cell Mol Med 15, 1505, 2011.
48. Goshima, J., Goldberg, V.M., and Caplan, A.I. The origin of bone formed in composite grafts of porous calcium phosphate ceramic loaded with marrow cells. Clin Orthop Relat Res, 274, 1991.
49. Gurkan, U.A., and Akkus, O. The mechanical environment of bone marrow: a review. Ann Biomed Eng 36, 1978, 2008.
50. Gao, D., Nolan, D., McDonnell, K., Vahdat, L., Benezra, R., Altorki, N., and Mittal, V. Bone marrow-derived endothelial progenitor cells contribute to the angiogenic switch in tumor growth and metastatic progression. Biochim Biophys Acta 1796, 33, 2009.
51. Zhukareva, V., Obrocka, M., Houle, J.D., Fischer, I., and Neuhuber, B. Secretion profile of human bone marrow stromal cells: donor variability and response to inflammatory stimuli. Cytokine 50, 317, 2010.
52. Santos, M.I., and Reis, R.L. Vascularization in bone tissue engineering: physiology, current strategies, major hurdles and future challenges. Macromol Biosci 10, 12, 2010.
53. Phelps, E.A., and Garcia, A.J. Engineering more than a cell: vascularization strategies in tissue engineering. Curr Opin Biotechnol 21, 704, 2010.
54. Quirici, N., Soligo, D., Caneva, L., Servida, F., Bossolasco, P., and Deliliers, G.L. Differentiation and expansion of endothelial cells from human bone marrow CD133( + ) cells. Br J Haematol 115, 186, 2001.
55. Asahara, T., Murohara, T., Sullivan, A., Silver, M., van der Zee, R., Li, T., Witzenbichler, B., Schatteman, G., and Isner, J.M. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275, 964, 1997.
56. Murohara, T., Ikeda, H., Duan, J., Shintani, S., Sasaki, K., Eguchi, H., Onitsuka, I., Matsui, K., and Imaizumi, T. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J Clin Invest 105, 1527, 2000.
57. Asahara, T., Masuda, H., Takahashi, T., Kalka, C., Pastore, C., Silver, M., Kearne, M., Magner, M., and Isner, J.M. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85, 221, 1999.
58. Zemani, F., Benisvy, D., Galy-Fauroux, I., Lokajczyk, A., Colliec-Jouault, S., Uzan, G., Fischer, A.M., and Boisson- Vidal, C. Low-molecular-weight fucoidan enhances the proangiogenic phenotype of endothelial progenitor cells. Biochem Pharmacol 70, 1167, 2005.